Chemoresistance in small cell lung cancer
Emerging evidence identifies HMGB1 as a critical regulator of chemoresistance in small cell lung cancer (SCLC).
Chemoresistance in small cell lung cancer Read More »
Emerging evidence identifies HMGB1 as a critical regulator of chemoresistance in small cell lung cancer (SCLC).
Chemoresistance in small cell lung cancer Read More »
A study reveals that highly metastatic cancer cells possessing a functional Trx/TrxR axis respond robustly to the CXCL12/HMGB1 heterocomplex, exhibiting enhanced directional migration and invasiveness through CXCR4 activation.
Tumor cell migration Read More »
The HMGB1–CXCL12 complex forms in injured muscle and can be detected by hybridization assay, while blocking HMGB1 with antibodies or glycyrrhizin effectively prevents the recruitment of inflammatory cells.
Video-insight | We can detect the HMGB1-CXCL12 complex in injured muscle and target it Read More »
In the acute ischemic phase, HMGB1 protein contributes to thromboinflammation, blood–brain barrier disruption, and immune cell activation, amplifying tissue injury.
Ischemic Stroke and neuroinflammation Read More »
NMR analysis revealed that HMGB1 and CXCL12 form a labile complex, primarily through HMGB1’s Box A, and in muscle injury this complex correlates with HMGB1 translocation from nuclei to cytoplasm and its active release to recruit inflammatory cells.
Video-insight | NMR shows that HMGB1 and CXCL12 form a complex Read More »
Recent findings provide mechanistic clarity, positioning Selenoprotein O (SelO) as a negative regulator of HMGB1-driven inflammation and ROS-dependent neutrophil extracellular trap (NET) formation.
Progression of acute Liver inflammation Read More »
Cell migration toward HMGB1 depends on the chemokine CXCL12 and its receptor CXCR4, as HMGB1 and CXCL12 act synergistically to induce chemoattraction even at non-active concentrations individually.
Video-insight | How do cells migrate toward HMGB1? Read More »
We are glad to announce an interesting paper from Prof Claudia Biguetti, about a study in which has been used 3S-HMGB1, LPS-Free (HM-130) produced by HMGBiotech.
Osseointegration under diabetic conditions Read More »
Under conditions of stress or tissue damage such as ischemia-reperfusion, cells actively secrete HMGB1, which serves as a key extracellular signal recruiting and activating inflammatory cells across multiple organs.
Video-insight | Extracellular HMGB1 recruits and activates inflammatory cells Read More »